Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2019

Open Access 01-12-2019 | Levonorgestrel | Research Article

Trends in dispensing oral emergency contraceptives and safety issues: a survey of German community pharmacists

Authors: André Said, Matthias Ganso, Leonard Freudewald, Martin Schulz

Published in: International Journal of Clinical Pharmacy | Issue 6/2019

Login to get access

Abstract

Background Oral emergency contraceptives containing levonorgestrel or ulipristal acetate are available without prescription and only in pharmacies in Germany since March 2015. Due to this change community pharmacists are responsible for evaluating whether the product is appropriate and to educate women on proper use. Objective To measure the utilization of emergency contraceptives without a prescription and describe potential concerns and safety issues identified by community pharmacists in Germany. Setting The Drug Commission of German Pharmacists' nationwide network of reference pharmacies which includes 860 community pharmacies. Methods Reference community pharmacies were asked to participate in the eleven-questions online survey. Respondents were asked to recall their experiences with oral emergency contraceptives in the past 3 months. Data were collected between January 8 and February 19, 2018. Main outcome measure The survey focused on the utilization of emergency contraceptives without a prescription in Germany, and on the pharmacists’ experiences with (potential) problems and concerns regarding safe use. Results In total, 555 community pharmacies (64.5%) participated. Overall 38.2% of community pharmacists stated they dispensed six to ten courses of emergency contraceptives within the past 3 months. In addition, 54.3% of the pharmacists estimated they dispensed emergency contraceptives exclusively without prescription and 35.9% dispensed more than 30% of emergency contraceptives during night-time and emergency services. Moreover, 82.8% of pharmacists stated that emergency contraceptives were requested not by the women concerned but a third person and 44.3% identified uncertainties in woman's self-diagnosis. Three out of four pharmacists had concerns about the effective and safe use of emergency contraceptives. In situations suggesting sexually transmitted diseases, or suspicion for use of force, 59.5% and 55.8% of the pharmacists, respectively, dispensed emergency contraceptives. In cases of acute health impairment or chronic disease, or (potentially) relevant drug/drug interaction, the vast majority (91.0% and 90.5%) did not. Here, most pharmacists referred to gynecologists. Conclusion Pharmacists had safety concerns when dispensing emergency contraceptives. Professional expertise in evaluating the need for oral emergency contraceptives and the proper use is needed.
Appendix
Available only for authorised users
Literature
1.
go back to reference Corbelli J, Bimla Schwarz E. Emergency contraception: a review. Minerva Ginecol. 2014;66:551–64.PubMed Corbelli J, Bimla Schwarz E. Emergency contraception: a review. Minerva Ginecol. 2014;66:551–64.PubMed
2.
go back to reference Najera DB. Emergency contraception: focus on the facts. JAAPA. 2016;29:20–4 (quiz 1).CrossRef Najera DB. Emergency contraception: focus on the facts. JAAPA. 2016;29:20–4 (quiz 1).CrossRef
3.
go back to reference Li H-WR, Lo SST, Ho P-C. Emergency contraception. Best Pract Res Clin Obstet Gynaecol. 2014;28:835–44.CrossRef Li H-WR, Lo SST, Ho P-C. Emergency contraception. Best Pract Res Clin Obstet Gynaecol. 2014;28:835–44.CrossRef
5.
go back to reference Apikoglu-Rabus S, Clark PM, Izzettin FV. Turkish pharmacists’ counseling practices and attitudes regarding emergency contraceptive pills. Int J Clin Pharm. 2012;34:579–86.CrossRef Apikoglu-Rabus S, Clark PM, Izzettin FV. Turkish pharmacists’ counseling practices and attitudes regarding emergency contraceptive pills. Int J Clin Pharm. 2012;34:579–86.CrossRef
6.
go back to reference von Rosen FT, von Rosen AJ, Müller-Riemenschneider F, Tinnemann P. Awareness and knowledge regarding emergency contraception in Berlin adolescents. Eur J Contracept Reprod Health Care. 2017;22:45–52.CrossRef von Rosen FT, von Rosen AJ, Müller-Riemenschneider F, Tinnemann P. Awareness and knowledge regarding emergency contraception in Berlin adolescents. Eur J Contracept Reprod Health Care. 2017;22:45–52.CrossRef
7.
go back to reference Higgins SJ, Hattingh HL. Requests for emergency contraception in community pharmacy: an evaluation of services provided to mystery patients. Res Soc Adm Pharm. 2013;9:114–9.CrossRef Higgins SJ, Hattingh HL. Requests for emergency contraception in community pharmacy: an evaluation of services provided to mystery patients. Res Soc Adm Pharm. 2013;9:114–9.CrossRef
8.
go back to reference Parsons J, Adams C, Aziz N, Holmes J, Jawad R, Whittlesea C. Evaluation of a community pharmacy delivered oral contraception service. J Fam Plann Reprod Health Care. 2013;39:97–101.CrossRef Parsons J, Adams C, Aziz N, Holmes J, Jawad R, Whittlesea C. Evaluation of a community pharmacy delivered oral contraception service. J Fam Plann Reprod Health Care. 2013;39:97–101.CrossRef
9.
go back to reference Schulz M, Goebel R, Schumann C, Zagermann-Muncke P. Non-prescription dispensing of emergency oral contraceptives: Recommendations from the German Federal Chamber of Pharmacists [Bundesapothekerkammer]. Pharm Pract (Granada). 2016;14(3):828.CrossRef Schulz M, Goebel R, Schumann C, Zagermann-Muncke P. Non-prescription dispensing of emergency oral contraceptives: Recommendations from the German Federal Chamber of Pharmacists [Bundesapothekerkammer]. Pharm Pract (Granada). 2016;14(3):828.CrossRef
10.
go back to reference Carten ML, Kiser JJ, Kwara A, Mawhinney S, Cu-Uvin S. Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and Efavirenz. Infect Dis Obstet Gynecol. 2012;2012:137192.CrossRef Carten ML, Kiser JJ, Kwara A, Mawhinney S, Cu-Uvin S. Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and Efavirenz. Infect Dis Obstet Gynecol. 2012;2012:137192.CrossRef
11.
go back to reference Fok WK, Blumenthal PD. Update on emergency contraception. Curr Opin Obstet Gynecol. 2016;28:522–9.CrossRef Fok WK, Blumenthal PD. Update on emergency contraception. Curr Opin Obstet Gynecol. 2016;28:522–9.CrossRef
12.
go back to reference Ganso M, Goebel R, Melhorn S, Schrenk D, Schulz M. Lipoid pneumonia associated with lipid-containing nasal sprays and nose drops. Laryngorhinootologie. 2016;95:534–9.CrossRef Ganso M, Goebel R, Melhorn S, Schrenk D, Schulz M. Lipoid pneumonia associated with lipid-containing nasal sprays and nose drops. Laryngorhinootologie. 2016;95:534–9.CrossRef
13.
go back to reference Said A, Goebel R, Ganso M, Zagermann-Muncke P, Schulz M. Drug shortages may compromise patient safety: results of a survey of the reference pharmacies of the Drug Commission of German Pharmacists. Health Policy. 2018;122:1302–9.CrossRef Said A, Goebel R, Ganso M, Zagermann-Muncke P, Schulz M. Drug shortages may compromise patient safety: results of a survey of the reference pharmacies of the Drug Commission of German Pharmacists. Health Policy. 2018;122:1302–9.CrossRef
15.
go back to reference Raymond EG, Trussell J, Polis CB. Population effect of increased access to emergency contraceptive pills: a systematic review. Obstet Gynecol. 2007;109:181–8.CrossRef Raymond EG, Trussell J, Polis CB. Population effect of increased access to emergency contraceptive pills: a systematic review. Obstet Gynecol. 2007;109:181–8.CrossRef
16.
go back to reference Polis CB, Schaffer K, Blanchard K, Glasier A, Harper CC, Grimes DA. Advance provision of emergency contraception for pregnancy prevention (full review). Cochrane Database Syst Rev. 2007;2:CD005497. Polis CB, Schaffer K, Blanchard K, Glasier A, Harper CC, Grimes DA. Advance provision of emergency contraception for pregnancy prevention (full review). Cochrane Database Syst Rev. 2007;2:CD005497.
17.
go back to reference Kiechle M, Neuenfeldt M. Experience with oral emergency contraception since the OTC switch in Germany. Arch Gynecol Obstet. 2017;295:651–60.CrossRef Kiechle M, Neuenfeldt M. Experience with oral emergency contraception since the OTC switch in Germany. Arch Gynecol Obstet. 2017;295:651–60.CrossRef
18.
go back to reference Milosavljevic J, Bogavac-Stanojevic N, Krajnovic D, Mitrovic-Jovanovic A. Serbian gynecologists’ and pharmacists’ beliefs about emergency contraception. Women Health. 2017;57:508–19.CrossRef Milosavljevic J, Bogavac-Stanojevic N, Krajnovic D, Mitrovic-Jovanovic A. Serbian gynecologists’ and pharmacists’ beliefs about emergency contraception. Women Health. 2017;57:508–19.CrossRef
19.
go back to reference Lawrence RE, Rasinski KA, Yoon JD, Curlin FA. Obstetrician–gynecologist physicians’ beliefs about emergency contraception: a national survey. Contraception. 2010;82:324–30.CrossRef Lawrence RE, Rasinski KA, Yoon JD, Curlin FA. Obstetrician–gynecologist physicians’ beliefs about emergency contraception: a national survey. Contraception. 2010;82:324–30.CrossRef
20.
go back to reference Richman AR, Daley EM, Baldwin J, Kromrey J, O’Rourke K, Perrin K. The role of pharmacists and emergency contraception: are pharmacists’ perceptions of emergency contraception predictive of their dispensing practices? Contraception. 2012;86:370–5.CrossRef Richman AR, Daley EM, Baldwin J, Kromrey J, O’Rourke K, Perrin K. The role of pharmacists and emergency contraception: are pharmacists’ perceptions of emergency contraception predictive of their dispensing practices? Contraception. 2012;86:370–5.CrossRef
22.
go back to reference Purohit N, Mathur R, Bakhshi P. Knowledge and use of emergency contraceptive pill: an analysis of perception and practice among unmarried urban women. J Fam Med Prim Care. 2013;2:376–80.CrossRef Purohit N, Mathur R, Bakhshi P. Knowledge and use of emergency contraceptive pill: an analysis of perception and practice among unmarried urban women. J Fam Med Prim Care. 2013;2:376–80.CrossRef
23.
go back to reference Simmons RG, Shattuck DC, Jennings VH. Assessing the efficacy of an app-based method of family planning: the Dot Study Protocol. JMIR Res Protoc. 2017;6(1):e5.CrossRef Simmons RG, Shattuck DC, Jennings VH. Assessing the efficacy of an app-based method of family planning: the Dot Study Protocol. JMIR Res Protoc. 2017;6(1):e5.CrossRef
24.
go back to reference Duane M, Contreras A, Jensen ET, White A. The performance of fertility awareness-based method apps marketed to avoid pregnancy. J Am Board Fam Med. 2016;29:508–11.CrossRef Duane M, Contreras A, Jensen ET, White A. The performance of fertility awareness-based method apps marketed to avoid pregnancy. J Am Board Fam Med. 2016;29:508–11.CrossRef
25.
go back to reference Bouchard P. Selective progesterone receptor modulators: A class with multiple actions and applications in reproductive endocrinology, and gynecology. Gynecol Endocrinol. 2014;30:683–4.CrossRef Bouchard P. Selective progesterone receptor modulators: A class with multiple actions and applications in reproductive endocrinology, and gynecology. Gynecol Endocrinol. 2014;30:683–4.CrossRef
26.
go back to reference Shen J, Che Y, Showell E, Chen K, Cheng L. Interventions for emergency contraception. Cochrane Database Syst Rev. 2017;8:CD001324.PubMed Shen J, Che Y, Showell E, Chen K, Cheng L. Interventions for emergency contraception. Cochrane Database Syst Rev. 2017;8:CD001324.PubMed
27.
go back to reference Lee JK, Schwarz EB. The safety of available and emerging options for emergency contraception. Expert Opin Drug Saf. 2017;16:1163–71.CrossRef Lee JK, Schwarz EB. The safety of available and emerging options for emergency contraception. Expert Opin Drug Saf. 2017;16:1163–71.CrossRef
28.
go back to reference Mittal S. Emergency contraception: which is the best? Minerva Ginecol. 2016;68:687–99.PubMed Mittal S. Emergency contraception: which is the best? Minerva Ginecol. 2016;68:687–99.PubMed
29.
go back to reference Upadhya KK, Santelli JS, Raine-Bennett TR, Kottke MJ, Grossman D. Over-the-counter access to oral contraceptives for adolescents. J Adolesc Health. 2017;60:634–40.CrossRef Upadhya KK, Santelli JS, Raine-Bennett TR, Kottke MJ, Grossman D. Over-the-counter access to oral contraceptives for adolescents. J Adolesc Health. 2017;60:634–40.CrossRef
30.
go back to reference Cleland K, Bass J, Doci F, Foster AM. Access to emergency contraception in the over-the-counter era. Womens Health Issues. 2016;26:622–7.CrossRef Cleland K, Bass J, Doci F, Foster AM. Access to emergency contraception in the over-the-counter era. Womens Health Issues. 2016;26:622–7.CrossRef
31.
go back to reference Berger K, Eickhoff C, Schulz M. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany. J Clin Pharm Ther. 2005;30:45–57.CrossRef Berger K, Eickhoff C, Schulz M. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany. J Clin Pharm Ther. 2005;30:45–57.CrossRef
33.
go back to reference Wilkinson TA, Rafie S, Clark PD, Carroll AE, Miller E. Evaluating community pharmacy responses about levonorgestrel emergency contraception by mystery caller characteristics. J Adolesc Health. 2018;63:32–6.CrossRef Wilkinson TA, Rafie S, Clark PD, Carroll AE, Miller E. Evaluating community pharmacy responses about levonorgestrel emergency contraception by mystery caller characteristics. J Adolesc Health. 2018;63:32–6.CrossRef
34.
go back to reference Thomin A, Keller V, Darai E, Chabbert-Buffet N. Consequences of emergency contraceptives: the adverse effects. Expert Opin Drug Saf. 2014;13:893–902.CrossRef Thomin A, Keller V, Darai E, Chabbert-Buffet N. Consequences of emergency contraceptives: the adverse effects. Expert Opin Drug Saf. 2014;13:893–902.CrossRef
35.
go back to reference Cleland K, Raymond EG, Westley E, Trussell J. Emergency contraception review: evidence-based recommendations for clinicians. Clin Obstet Gynecol. 2014;57:741–50.CrossRef Cleland K, Raymond EG, Westley E, Trussell J. Emergency contraception review: evidence-based recommendations for clinicians. Clin Obstet Gynecol. 2014;57:741–50.CrossRef
36.
go back to reference Society for Adolescent Health and Medicine. Emergency contraception for adolescents and young adults: guidance for health care professionals. J Adolesc Health. 2016;58:245–8.CrossRef Society for Adolescent Health and Medicine. Emergency contraception for adolescents and young adults: guidance for health care professionals. J Adolesc Health. 2016;58:245–8.CrossRef
37.
go back to reference Whelan AM, Langille DB, Hurst E. Nova Scotia pharmacists’ knowledge of, experiences with and perception of factors interfering with their ability to provide emergency contraceptive pill consultations. Int J Pharm Pract. 2013;21:314–21.CrossRef Whelan AM, Langille DB, Hurst E. Nova Scotia pharmacists’ knowledge of, experiences with and perception of factors interfering with their ability to provide emergency contraceptive pill consultations. Int J Pharm Pract. 2013;21:314–21.CrossRef
Metadata
Title
Trends in dispensing oral emergency contraceptives and safety issues: a survey of German community pharmacists
Authors
André Said
Matthias Ganso
Leonard Freudewald
Martin Schulz
Publication date
01-12-2019
Publisher
Springer International Publishing
Keyword
Levonorgestrel
Published in
International Journal of Clinical Pharmacy / Issue 6/2019
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-019-00911-6

Other articles of this Issue 6/2019

International Journal of Clinical Pharmacy 6/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.